CU2010

Product Overview

CU2010 is an investigational antifibrinolytic agent designed to limit blood loss during surgery.

Our clinical program for CU2010 is being run out of our Leipzig, Germany office. We acquired the product from Curacyte AG in August of 2008. CU2010 entered into a Phase Ia clinical trial in Switzerland in July 2009.

Toxicology, pharmacokinetic and efficacy studies in animals have been completed. In preclinical studies, CU2010 has demonstrated a pharmacokinetic profile in the surgical setting with a rapid onset and offset of effect, due to its short half life.